SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 25, 2012
(Exact name of registrant as specified in its charter)
Registrants telephone number, including area code: (303) 439-2085
ITEM 5.02 GENETHERA ACQUISITION OF APPLIED GENETICS
On January 3, 2012, the Shareholders of Applied Genetics met in Monterrey, Mexico and unanimously approved GeneThera offer to acquire the majority of the Class A Shares of Applied Genetics. GeneThera, Inc. acquired an additional 40% of Applied Genetics shares in addition to the 50% Shares already owned by the Company. Moreover, Applied Genetics Shareholders approved the sale of 10% of the Class A Shares to Dr. Felipe Villanueva Zavala. Upon closing of the transaction, GeneThera ownership of Applied Genetics is equal to 90% of the total Class A Outstanding Shares.
Item 9.01 EXHIBITS
Shareholders Meeting and Resolution for GeneThera to Acquire another
40% of Applied Genetics;
Press Release dated January 25, 2012 announcing GeneThera Acquires Applied
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
a Nevada Corporation
Antonio Milici, Chief Executive Officer
Date: January 25, 2012